Peter Blume-Jensen

Insider Reports History

Entity
Individual
Location
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, Massachusetts
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Blume-Jensen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. President and CEO, Director Common Stock 2.5M $17.6M $7.02 Aug 14, 2024 Direct
Acrivon Therapeutics, Inc. President and CEO, Director Common Stock 317K $2.23M $7.02 Aug 14, 2024 Indirect

Insider Reports Filed by Peter Blume-Jensen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Aug 14, 2024 1 -$420K 4 Aug 16, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. May 14, 2024 1 -$459K 4 May 16, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Feb 14, 2024 1 -$142K 4 Feb 16, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2023 1 -$1.21M 4 Nov 16, 2023 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Aug 21, 2023 1 $0 4 Aug 23, 2023 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. May 31, 2023 2 $130K 4 Jun 1, 2023 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 6 $0 4 Nov 16, 2022 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 President and CEO, Director